The Veterinary Vaccines Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others).
Veterinary Vaccines are biological preparations used to stimulate an immune response in animals against specific pathogens, thereby protecting them from infectious diseases. Veterinary vaccines play a crucial role in preventing and controlling diseases in various animal species, including livestock, companion animals, poultry, aquaculture species, and wildlife. These vaccines are developed using inactivated or attenuated forms of pathogens, recombinant proteins, subunit antigens, or nucleic acid-based constructs to elicit protective immunity without causing disease. Veterinary vaccines target a wide range of infectious agents, including bacteria, viruses, parasites, and fungi, and are administered through various routes such as injection, oral ingestion, or intranasal delivery. Vaccination programs are tailored to the specific disease risks, epidemiological factors, and production systems of each animal population, with considerations for vaccine efficacy, safety, and duration of immunity. Veterinary vaccines not only protect individual animals from diseases but also contribute to herd immunity, biosecurity, and public health by reducing the spread of zoonotic pathogens and minimizing the need for antimicrobial treatments in animal agriculture. With ongoing advancements in vaccine technology, adjuvant formulations, and vaccine delivery systems, veterinary vaccines continue to evolve, offering improved efficacy, safety profiles, and compatibility with global disease control efforts. Veterinary vaccination remains a cornerstone of preventive veterinary medicine, supporting sustainable animal production, safeguarding animal health and welfare, and promoting the responsible use of antimicrobials in veterinary practice.
A prominent trend in the veterinary vaccines market is the increasing focus on preventive healthcare in animal husbandry. With growing concerns about zoonotic diseases, antimicrobial resistance, and food safety, there's a heightened emphasis on preventing infectious diseases in livestock and companion animals through vaccination. Animal producers and veterinarians are recognizing the importance of vaccination as a cost-effective and sustainable approach to disease control and herd health management. Consequently, there's a rising demand for veterinary vaccines that provide broad-spectrum protection against prevalent pathogens and emerging infectious diseases. This trend is driving market growth and innovation in vaccine technologies, delivery systems, and disease surveillance strategies tailored to the diverse needs of animal agriculture and companion animal care.
A key driver fueling the growth of the veterinary vaccines market is the globalization of livestock production and intensification of animal farming practices. As the global population grows and dietary preferences shift towards animal protein, there's increasing demand for meat, milk, and eggs, driving expansion and consolidation of livestock operations worldwide. However, the concentration of animals in large-scale production facilities increases the risk of disease outbreaks and transmission, necessitating robust vaccination programs to maintain herd health and productivity. Additionally, the intensification of animal farming practices, such as high-density housing and intensive breeding, creates favorable conditions for pathogen spread and amplification, highlighting the importance of vaccination as a preventive measure. The globalization and intensification of animal agriculture are driving market demand for veterinary vaccines and stimulating investment in research, development, and manufacturing of novel vaccine formulations and delivery technologies.
An opportunity for growth in the veterinary vaccines market lies in the development of next-generation vaccines targeting emerging infectious diseases and the implementation of a One Health approach to disease control. Emerging infectious diseases, such as avian influenza, African swine fever, and bovine respiratory syncytial virus, pose significant threats to animal health, food security, and public health. There's potential for companies to invest in research and development to develop vaccines that provide rapid and effective protection against emerging pathogens, leveraging advances in molecular biology, immunology, and vaccine technology. Additionally, there's an opportunity to adopt a One Health approach that recognizes the interconnectedness of human, animal, and environmental health, and promotes collaborative efforts to prevent and control zoonotic diseases through vaccination. By addressing emerging disease threats and embracing a One Health perspective, companies can contribute to improved animal welfare, sustainable agriculture, and public health outcomes, while seizing opportunities for market expansion and leadership in the veterinary vaccines industry.
The fastest-growing segment in the Veterinary Vaccines Market is Companion Animal Vaccines, particularly Canine Vaccines within this category. This growth is driven by several factors, including the increasing pet ownership rates, rising awareness about preventive healthcare for pets, and advancements in vaccine technology. Canine vaccines play a crucial role in protecting dogs from a wide range of infectious diseases, including distemper, parvovirus, rabies, and kennel cough. The growing trend of humanization of pets, where pets are considered part of the family and receive similar healthcare attention, further boosts the demand for companion animal vaccines. Additionally, the development of novel vaccine technologies such as recombinant vaccines, which offer improved efficacy and safety profiles, contributes to the rapid growth of Canine Vaccines in the Veterinary Vaccines Market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAptimmune Biologics Inc, Biogénesis Bagó S.A., Biovac Biotech, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Ltd, Ceva Santé Animale, China Animal Husbandry Group, Elanco Animal Health (Eli Lilly and Company), Endovac Animal Health, Hester Biosciences Ltd, HIPRA - Laboratorios Hipra S.A., Indian Immunologicals Ltd, Intas Pharmaceuticals Ltd, Jinyu Bio-technology Co. Ltd, Laboratoire LCV, Merck & Co. Inc, Neogen Corp, Ourofino Saúde Animal Ltda., Phibro Animal Health Corp, Tianjin Ringpu Bio-Technology Co. Ltd, Torigen Pharmaceuticals Inc, Vaxxinova International BV, VEROVACCiNES GmbH, Virbac SA, Zoetis Inc
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Aptimmune Biologics Inc
Biogénesis Bagó S.A.
Biovac Biotech
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Ltd
Ceva Santé Animale
China Animal Husbandry Group
Elanco Animal Health (Eli Lilly and Company)
Endovac Animal Health
Hester Biosciences Ltd
HIPRA - Laboratorios Hipra S.A.
Indian Immunologicals Ltd
Intas Pharmaceuticals Ltd
Jinyu Bio-technology Co. Ltd
Laboratoire LCV
Merck & Co. Inc
Neogen Corp
Ourofino Saúde Animal Ltda.
Phibro Animal Health Corp
Tianjin Ringpu Bio-Technology Co. Ltd
Torigen Pharmaceuticals Inc
Vaxxinova International BV
VEROVACCiNES GmbH
Virbac SA
Zoetis Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Veterinary Vaccines Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Veterinary Vaccines Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Veterinary Vaccines Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Veterinary Vaccines Market Size Outlook, $ Million, 2021 to 2030
3.2 Veterinary Vaccines Market Outlook by Type, $ Million, 2021 to 2030
3.3 Veterinary Vaccines Market Outlook by Product, $ Million, 2021 to 2030
3.4 Veterinary Vaccines Market Outlook by Application, $ Million, 2021 to 2030
3.5 Veterinary Vaccines Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Veterinary Vaccines Industry
4.2 Key Market Trends in Veterinary Vaccines Industry
4.3 Potential Opportunities in Veterinary Vaccines Industry
4.4 Key Challenges in Veterinary Vaccines Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Veterinary Vaccines Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Veterinary Vaccines Market Outlook by Segments
7.1 Veterinary Vaccines Market Outlook by Segments, $ Million, 2021- 2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
8 North America Veterinary Vaccines Market Analysis and Outlook To 2030
8.1 Introduction to North America Veterinary Vaccines Markets in 2024
8.2 North America Veterinary Vaccines Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Veterinary Vaccines Market size Outlook by Segments, 2021-2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
9 Europe Veterinary Vaccines Market Analysis and Outlook To 2030
9.1 Introduction to Europe Veterinary Vaccines Markets in 2024
9.2 Europe Veterinary Vaccines Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Veterinary Vaccines Market Size Outlook by Segments, 2021-2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
10 Asia Pacific Veterinary Vaccines Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Veterinary Vaccines Markets in 2024
10.2 Asia Pacific Veterinary Vaccines Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Veterinary Vaccines Market size Outlook by Segments, 2021-2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
11 South America Veterinary Vaccines Market Analysis and Outlook To 2030
11.1 Introduction to South America Veterinary Vaccines Markets in 2024
11.2 South America Veterinary Vaccines Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Veterinary Vaccines Market size Outlook by Segments, 2021-2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
12 Middle East and Africa Veterinary Vaccines Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Veterinary Vaccines Markets in 2024
12.2 Middle East and Africa Veterinary Vaccines Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Veterinary Vaccines Market size Outlook by Segments, 2021-2030
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Aptimmune Biologics Inc
Biogénesis Bagó S.A.
Biovac Biotech
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Ltd
Ceva Santé Animale
China Animal Husbandry Group
Elanco Animal Health (Eli Lilly and Company)
Endovac Animal Health
Hester Biosciences Ltd
HIPRA - Laboratorios Hipra S.A.
Indian Immunologicals Ltd
Intas Pharmaceuticals Ltd
Jinyu Bio-technology Co. Ltd
Laboratoire LCV
Merck & Co. Inc
Neogen Corp
Ourofino Saúde Animal Ltda.
Phibro Animal Health Corp
Tianjin Ringpu Bio-Technology Co. Ltd
Torigen Pharmaceuticals Inc
Vaxxinova International BV
VEROVACCiNES GmbH
Virbac SA
Zoetis Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
-Bovine Vaccines
-Small Ruminant Vaccines
Companion Animal Vaccines
-Canine Vaccines
-Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Veterinary Vaccines Market is one of the lucrative growth markets, poised to register a 6.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Aptimmune Biologics Inc, Biogénesis Bagó S.A., Biovac Biotech, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Ltd, Ceva Santé Animale, China Animal Husbandry Group, Elanco Animal Health (Eli Lilly and Company), Endovac Animal Health, Hester Biosciences Ltd, HIPRA - Laboratorios Hipra S.A., Indian Immunologicals Ltd, Intas Pharmaceuticals Ltd, Jinyu Bio-technology Co. Ltd, Laboratoire LCV, Merck & Co. Inc, Neogen Corp, Ourofino Saúde Animal Ltda., Phibro Animal Health Corp, Tianjin Ringpu Bio-Technology Co. Ltd, Torigen Pharmaceuticals Inc, Vaxxinova International BV, VEROVACCiNES GmbH, Virbac SA, Zoetis Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume